BioCardia, Inc.

BioCardia, Inc.

BioCardia, Inc.

Overview
Date Founded

1994

Headquarters

125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070

Type of Company

Public

Employees (Worldwide)

27

Industries

Biotechnology

Company Description

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.

Executives & Employees

Chief Executive Officer & President

Vice President of Finance

Chief Scientific Officer

Chief Medical Officer

Vice President-Clinical Affairs

Vice President, Operations

Board of Directors

Founder at Vascular Science, Inc.

Executive Director at W. R. Kenan Jr. Charitable Trust

Former Chairman, President & Chief Executive Officer at Continucare Corp.

Chief Financial Officer at Sera Prognostics, Inc.

President & Chief Executive Officer at WareITis Technologies LLC

Chief Executive Officer & President at BioCardia, Inc.

Director at BioCardia, Inc.

Chief Financial Officer & Vice President-Finance at United Data Technologies, Inc.

Paths to BioCardia, Inc.
Potential Connections via
Relationship Science
You
BioCardia, Inc.
Recent Transactions
Details Hidden

BioCardia, Inc. raised money in a private placement transaction

Details Hidden

BioCardia, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Advisors & Consultants
Advisor

Founder at Cardiovascular Institute of the South

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Advisor

Member, Medical Advisory Board at Lyra Therapeutics, Inc.

Clients

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Key Stats and Financials As of 2018
Market Capitalization
$25M
Total Enterprise Value
$40.7M
Earnings Per Share
$-3.28
Revenue
$625K
Net Profit
$-14M
EBITDA
$-14M
EBITDAMargin
-2,242.24%
Total Debt
$0
Total Equity
$3.79M
Enterprise Value Sales
65.11x
TEVNet Income
-2.91x
Debt TEV
0x
Suppliers
Zimmer Biomet Holdings, Inc. Medical Support Services | Warsaw, IN

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Moderna, Inc. Biotechnology - Cambridge, Massachusetts

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Baxter International, Inc. Medical Products & Equipment - Deerfield, IL

Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2011 sales of $13.9 billion and has approximately 48,500 employees.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by BioCardia, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of BioCardia, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and BioCardia, Inc..